Tag: HIF-2α inhibitor

Pediatric renal and thyroid cancer rates increase

Belzutifan plus cabozantinib for immunotherapy pre-treated advanced renal cell carcinoma

byDaniel Goldshteinand1 others

April 17, 2023

1.The objective response rate was 30.8% with the majority attributing to partial response. 2. Most common adverse events (grade 3 ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Roche and NVIDIA deploy the pharmaceutical industry’s largest artificial intelligence factory
Apolipoprotein E mimetic peptide CN-105 may be safe and feasible for delirium prevention in older surgical patients
Emergency department screening tool predicts firearm violence risk

No Result

View All Result